Will Lester

8.6k total citations · 5 hit papers
105 papers, 5.2k citations indexed

About

Will Lester is a scholar working on Hematology, Atomic and Molecular Physics, and Optics and Surgery. According to data from OpenAlex, Will Lester has authored 105 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hematology, 26 papers in Atomic and Molecular Physics, and Optics and 16 papers in Surgery. Recurrent topics in Will Lester's work include Platelet Disorders and Treatments (26 papers), Advanced Chemical Physics Studies (18 papers) and Complement system in diseases (12 papers). Will Lester is often cited by papers focused on Platelet Disorders and Treatments (26 papers), Advanced Chemical Physics Studies (18 papers) and Complement system in diseases (12 papers). Will Lester collaborates with scholars based in United Kingdom, United States and France. Will Lester's co-authors include Reinhard Schinke, Marie Scully, J. Schaefer, Michael Laffan, Glenn F. Pierce, Savita Rangarajan, John Pasi, Wing Yen Wong, Bella Madan and Peter Reynolds and has published in prestigious journals such as Science, New England Journal of Medicine and Nature Medicine.

In The Last Decade

Will Lester

98 papers receiving 5.0k citations

Hit Papers

Pathologic Antibodies to ... 2017 2026 2020 2023 2021 2017 2021 2020 2020 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Will Lester 1.9k 1.2k 1.2k 716 637 105 5.2k
Normand Blais 469 0.2× 2.6k 2.1× 590 0.5× 189 0.3× 745 1.2× 228 6.4k
Luigi De Marco 1.6k 0.9× 1.3k 1.1× 446 0.4× 316 0.4× 337 0.5× 75 4.0k
Henk M.W. Verheul 855 0.5× 531 0.4× 977 0.8× 296 0.4× 5.6k 8.8× 485 14.0k
J. Delaunay 1.7k 0.9× 292 0.2× 684 0.6× 653 0.9× 2.1k 3.3× 341 7.6k
Surjit Singh 418 0.2× 382 0.3× 1.9k 1.6× 320 0.4× 891 1.4× 384 6.6k
Takashi Okamura 1.6k 0.8× 206 0.2× 432 0.4× 398 0.6× 1.4k 2.2× 294 6.1k
Jacob M. Rowe 5.2k 2.7× 1.8k 1.4× 158 0.1× 265 0.4× 3.1k 4.9× 237 11.1k
E. Benedetti 329 0.2× 3.3k 2.6× 1.7k 1.4× 106 0.1× 642 1.0× 299 8.1k
John A. McIntyre 857 0.5× 427 0.3× 318 0.3× 231 0.3× 525 0.8× 205 4.4k
William J. Hogan 3.9k 2.1× 144 0.1× 450 0.4× 296 0.4× 2.5k 3.9× 413 7.1k

Countries citing papers authored by Will Lester

Since Specialization
Citations

This map shows the geographic impact of Will Lester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Will Lester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Will Lester more than expected).

Fields of papers citing papers by Will Lester

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Will Lester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Will Lester. The network helps show where Will Lester may publish in the future.

Co-authorship network of co-authors of Will Lester

This figure shows the co-authorship network connecting the top 25 collaborators of Will Lester. A scholar is included among the top collaborators of Will Lester based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Will Lester. Will Lester is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fratter, Carl, Will Lester, Charles Percy, et al.. (2025). The diagnostic utility of genetic testing in inherited thrombocytopenia: regional multicenter tertiary experience. Research and Practice in Thrombosis and Haemostasis. 9(3). 102869–102869.
2.
Stubbs, Matthew, Prabhu Gounder, Matthew Carter, et al.. (2025). Long-term follow-up outcomes in congenital thrombotic thrombocytopenic purpura. Blood. 146(20). 2457–2463.
3.
Russell, Chris B., Christian Vettermann, Suresh Agarwal, et al.. (2025). Recombinant Adeno-Associated Virus Integration Profiles in Nonhuman Primates and Gene Therapy Participants after Treatment with Valoctocogene Roxaparvovec. Human Gene Therapy. 36(13-14). 945–955.
4.
Howells, Lara, et al.. (2025). Impact of new medications on the treatment of immune TTP. Blood. 145(13). 1353–1357. 1 indexed citations
5.
Symington, Emily, Savita Rangarajan, Will Lester, et al.. (2024). Valoctocogene roxaparvovec gene therapy provides durable haemostatic control for up to 7 years for haemophilia A. Haemophilia. 30(5). 1138–1147. 14 indexed citations
6.
Symington, Emily, Savita Rangarajan, Will Lester, et al.. (2024). Long‐term safety and efficacy outcomes of valoctocogene roxaparvovec gene transfer up to 6 years post‐treatment. Haemophilia. 30(2). 320–330. 17 indexed citations
7.
Platton, Sean, Peter Baker, Annette Bowyer, et al.. (2024). Guideline for laboratory diagnosis and monitoring of von Willebrand disease: A joint guideline from the United Kingdom Haemophilia Centre Doctors' Organisation and the British Society for Haematology. British Journal of Haematology. 204(5). 1714–1731. 12 indexed citations
8.
Lester, Will, Niki L. Walker, Kailash P. Bhatia, et al.. (2023). British Society for Haematology guideline for anticoagulant management of pregnant individuals with mechanical heart valves. British Journal of Haematology. 202(3). 465–478. 9 indexed citations
9.
Doyle, Andrew J., Matthew Stubbs, Tina Dutt, et al.. (2022). Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy. Blood. 141(3). 285–294. 10 indexed citations
10.
Bowyer, Annette, Elaine Gray, Paul Murphy, et al.. (2022). Laboratory coagulation tests and recombinant porcine factor VIII: A United Kingdom Haemophilia Centre Doctors’ Organisation guideline. Haemophilia. 28(3). 515–519. 8 indexed citations
11.
Fong, Sylvia, Bridget Yates, Choong‐Ryoul Sihn, et al.. (2022). Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia A. Nature Medicine. 28(4). 789–797. 77 indexed citations
12.
Shaw, Rebecca, et al.. (2021). Intracranial hemorrhage in immune thrombotic thrombocytopenic purpura treated with caplacizumab. Journal of Thrombosis and Haemostasis. 19(8). 1922–1925. 9 indexed citations
14.
Hann, Angus, Hermien Hartog, Will Lester, et al.. (2021). Early Adverse Outcomes of Liver Allografts from Donors with COVID Vaccine Induced Thrombosis and Thrombocytopenia Syndrome. HPB. 23. S975–S975.
15.
Neuberger, James, Jai V. Patel, Helen Caldwell, et al.. (2020). Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology. Gut. 69(8). 1382–1403. 229 indexed citations breakdown →
16.
Jenkins, P. Vincent, Annette Bowyer, Elaine Gray, et al.. (2019). Laboratory coagulation tests and emicizumab treatment A United Kingdom Haemophilia Centre Doctors' Organisation guideline. Haemophilia. 26(1). 151–155. 51 indexed citations
17.
Gray, Elaine, Steve Kitchen, Annette Bowyer, et al.. (2019). Laboratory measurement of factor replacement therapies in the treatment of congenital haemophilia: A United Kingdom Haemophilia Centre Doctors’ Organisation guideline. Haemophilia. 26(1). 6–16. 36 indexed citations
18.
Seidl, Peter Rudolf, et al.. (1996). 中性アルコールでの炭素-炭素および炭素-水素超共役. Journal of Molecular Structure. 388. 85–95. 1 indexed citations
19.
Lester, Will, et al.. (1994). Monte Carlo Methods in Ab Initio Quantum Chemistry. 239 indexed citations
20.
Pfuetze, Karl H., et al.. (1965). PHOTOCHROMOGENIC MYCOBACTERIAL PULMONARY DISEASE.. PubMed. 92. 470–5. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026